Tacrolimus Ointment
Product Images NDC 0168-0417

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 0168-0417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton003percent (Carton003percent)

Carton003percent (Carton003percent)
This is a description of a topical medication called Tacrolimus Ointment 0.03% in a 60-gram tube. The dosage is to apply the ointment twice daily, and it is for dermatologic use only. The ointment should be stored at room temperature, and the package insert should be consulted for more information regarding dosage. The medication contains 0.03% tacrolimus and is manufactured by E. Fougera & Co., which is a division of Fougera Pharmaceuticals Inc. There are specific instructions on how to open the tube and store it, plus warnings to keep it out of reach of children. Finally, there is a code or Lot No., which is 400081, and the medication guide should be dispensed with the product.*
FDA Label Image

Carton01percent (Carton01percent)

Carton01percent (Carton01percent)
Tacrolimus Ointment 0.1% by Fougera® is a dermatologic drug that comes in a sealed 60-gram tube with a product insert. It contains 0.1% tacrolimus and is for external use only. The recommended dosage is twice a day. It is stored at a room temperature of 25°C with excursions allowed up to 15-30°C. Not for ophthalmic use, this drug should be kept out of reach of children. The packaging contains a medication guide that must be dispensed with the product. The ingredients include white petrolatum, mineral oil, propylene carbonate, white wax, and paraffin. The Lot No. and Expiration Date are located on the crimp of the tube.*
FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
This is a graph showing the Mean Erythema Score and confidence intervals at different time points (weeks) for three treatments: Vehicle, 0.03%, and 0.1%.*
FDA Label Image

Figure 4 (Image 05)

FDA Label Image

60g Tube 0.03% (Image 06)

60g Tube 0.03% (Image 06)
This is a medication called Fougera Tacrolimus Ointment with an NDC number of 0168-0417-60. It is for dermatologic use only, and each 60-gram tube contains 0.03% w/w of tacrolimus. The ointment is applied twice daily, and the dosage information is included in the package insert. The product should be stored at room temperature, and the seal should not be broken or missing. The tube has a Lot No. and Expiration Date on the crimp. Fougera Tacrolimus Ointment is manufactured by E.FOUGERA & CO, a division of Fougera Pharmaceuticals Inc, in Melville, New York, 11747.*
FDA Label Image

60g Container 0.1% (Image 08)

60g Container 0.1% (Image 08)
This is a description of a medication called "Tacrolimus Ointment 0.1%" by Fougera. The medication comes in a tube with a dosage of applying it twice a day. The package insert contains information about the dosage. The storage instructions suggest that it be stored at room temperature 25°C (77°F). The medication is sealed and should not be used if the seal is broken or missing. The packaging contains information regarding the Lot No. and Expiration Date. The medication is manufactured by E.Fougera & Co, a division of Fougera Pharmaceuticals Inc. The ointment is not for ophthalmic use and should be kept out of reach of children. The medication contains 0.19% wAv of tacrolimus, and the net weight of the tube is 60 grams.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.